- Home
- ALTS vs ANVS Comparison
ALTS vs ANVS Comparison
Compare ALTS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- ANVS
- Stock Information
- Founded
- ALTS 1976
- ANVS 2008
- Country
- ALTS United States
- ANVS United States
- Employees
- ALTS N/A
- ANVS N/A
- Industry
- ALTS
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- ANVS Health Care
- Exchange
- ALTS NYSE
- ANVS Nasdaq
- Market Cap
- ALTS 159.4M
- ANVS 44.6M
- IPO Year
- ALTS N/A
- ANVS 2020
- Fundamental
- Price
- ALTS $7.88
- ANVS $2.75
- Analyst Decision
- ALTS
- ANVS Strong Buy
- Analyst Count
- ALTS 0
- ANVS 4
- Target Price
- ALTS N/A
- ANVS $18.00
- AVG Volume (30 Days)
- ALTS 298.1K
- ANVS 437.3K
- Earning Date
- ALTS 08-18-2025
- ANVS 08-14-2025
- Dividend Yield
- ALTS N/A
- ANVS N/A
- EPS Growth
- ALTS N/A
- ANVS N/A
- EPS
- ALTS N/A
- ANVS N/A
- Revenue
- ALTS $18,046,000.00
- ANVS N/A
- Revenue This Year
- ALTS $185.91
- ANVS N/A
- Revenue Next Year
- ALTS $64.93
- ANVS N/A
- P/E Ratio
- ALTS N/A
- ANVS N/A
- Revenue Growth
- ALTS N/A
- ANVS N/A
- 52 Week Low
- ALTS $1.29
- ANVS $1.11
- 52 Week High
- ALTS $10.95
- ANVS $14.80
- Technical
- Relative Strength Index (RSI)
- ALTS 47.13
- ANVS 57.81
- Support Level
- ALTS $7.06
- ANVS $2.24
- Resistance Level
- ALTS $8.38
- ANVS $2.97
- Average True Range (ATR)
- ALTS 0.91
- ANVS 0.26
- MACD
- ALTS -0.17
- ANVS 0.02
- Stochastic Oscillator
- ALTS 33.51
- ANVS 65.58
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.